Systemic and local regulation of the growth plate

被引:418
作者
van der Eerden, BCJ
Karperien, M
Wit, JM
机构
[1] Leiden Univ, Med Ctr, Dept Pediat, NL-2300 RC Leiden, Netherlands
[2] Leiden Univ, Med Ctr, Dept Endocrinol & Metab Dis, NL-2300 RC Leiden, Netherlands
关键词
D O I
10.1210/er.2002-0033
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
The growth plate is the final target organ for longitudinal growth and results from chondrocyte proliferation and differentiation. During the first year of life, longitudinal growth rates are high, followed by a decade of modest longitudinal growth. The age at onset of puberty and the growth rate during the pubertal growth spurt ( which occurs under the influence of estrogens and GH) contribute to sex difference in final height between boys and girls. At the end of puberty, growth plates fuse, thereby ceasing longitudinal growth. It has been recognized that receptors for many hormones such as estrogen, GH, and glucocorticoids are present in or on growth plate chondrocytes, suggesting that these hormones may influence processes in the growth plate directly. Moreover, many growth factors, i.e., IGF-I, Indian hedgehog, PTHrP, fibroblast growth factors, bone morphogenetic proteins, and vascular endothelial growth factor, are now considered as crucial regulators of chondrocyte proliferation and differentiation. In this review, we present an update on the present perception of growth plate function and the regulation of chondrocyte proliferation and differentiation by systemic and local regulators of which most are now related to human growth disorders.
引用
收藏
页码:782 / 801
页数:20
相关论文
共 308 条
  • [1] The role of the resting zone in growth plate chondrogenesis
    Abad, V
    Meyers, JL
    Weise, M
    Gafni, RI
    Barnes, KM
    Nilsson, O
    Bacher, JD
    Baron, J
    [J]. ENDOCRINOLOGY, 2002, 143 (05) : 1851 - 1857
  • [2] The expression of thyroid hormone receptors in human bone
    Abu, EO
    Bord, S
    Horner, A
    Chatterjee, VKK
    Compston, JE
    [J]. BONE, 1997, 21 (02) : 137 - 142
  • [3] Abu EO, 1997, J CLIN ENDOCR METAB, V82, P3493, DOI 10.1210/jc.82.10.3493
  • [4] The localization of the functional glucocorticoid receptor α in human bone
    Abu, EO
    Horner, A
    Kusec, V
    Triffitt, JT
    Compston, JE
    [J]. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2000, 85 (02) : 883 - 889
  • [5] TARGETED DISRUPTION OF THE TISSUE INHIBITOR OF METALLOPROTEINASES GENE INCREASES THE INVASIVE BEHAVIOR OF PRIMITIVE MESENCHYMAL CELLS DERIVED FROM EMBRYONIC STEM-CELLS INVITRO
    ALEXANDER, CM
    WERB, Z
    [J]. JOURNAL OF CELL BIOLOGY, 1992, 118 (03) : 727 - 739
  • [6] Growth suppression by glucocorticoid therapy
    Allen, DB
    [J]. ENDOCRINOLOGY AND METABOLISM CLINICS OF NORTH AMERICA, 1996, 25 (03) : 699 - &
  • [7] Alvarez J, 2002, DEVELOPMENT, V129, P1913
  • [8] Matrix vesicles and calcification.
    H. Clarke Anderson
    [J]. Current Rheumatology Reports, 2003, 5 (3) : 222 - 226
  • [9] CHANGES IN RAT EPIPHYSEAL CARTILAGE AFTER TREATMENT WITH DEXAMETHASONE AND GLYCOSAMINOGLYCAN-PEPTIDE COMPLEX
    ANNEFELD, M
    [J]. PATHOLOGY RESEARCH AND PRACTICE, 1992, 188 (4-5) : 649 - 652
  • [10] BMP-5 deficiency alters chondrocytic activity in the mouse proximal tibial growth plate
    Bailón-Plaza, A
    Lee, AO
    Veson, EC
    Farnum, CE
    van der Meulen, MCH
    [J]. BONE, 1999, 24 (03) : 211 - 216